1CIBIS-II Investigatiors, Conunittes. The cardiac insufficiency bisoprolol study IICIBIS-II. Lancet, 1999,353:9-13.
2ME RIT-HF Study Group. Effect or metoprolol CRIXL in chronic heart failure;Metoprolol CR1 XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet, 1999, 353: 2001-2007.
3Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and morbidity in patients with chronic heart failure. N Engl J Med, 1996,334 : 1349-1355.
6Packer M,coats AIS, Fowler MB, et al. Effect of carvedilol on sur- vival in severe chronic heart failure. N EnglJ Med, 2001,344: 1651-1658.
7Brat BA, Ertl G, Held P, et al. Contemporary management of patients with left ventricular systolic dysfunction; results from the SPICE Registry. Eur Heart J, 1999,20 : 1182-1190.
1Cleland JG, Clark A. Has the survival of the heart failure population changed? Lessons from trials. Am J Cardiol, 1999,83:112D-119D.
2Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J, 1997,133:703-712.
3Gary R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA, 1995,273:1450-1456.
4Cleland JG, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet, 1998,352:19-28.
5Narang R, Cleland JG, Erhardt L, et al. Mode of death in chronic heart failure: a request for more accurate classification. Eur Heart J, 1996,17:1390-1403.
6Pierpont GL, Cohn JN, Franciosa JA. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Chest, 1978,73:8-13.
7Jugdutt BI, Khan MI. Effect of prolonged nitrate therapy on left ventricular remodeling after canine myocardial infarction. Circulation, 1994,89:2297-2307.
8Packer M, O′Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in servere chronic heart failure. N Engl J Med, 1996,335:1107-1114.
9Cohn JN, Ziesche S, Smith R, et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-Heft III. Circulation, 1997,96:856-863.
10The Cardiac Insufficiency Bisoprolol Study (CIBIS-II): a randomised trial. Lancet, 1999,353:9-13.
1Hjalmarson A,Goldstein S,Fagerberg B,et al.Effects of controlled-release metoprolol on total mortality,hospitalizations,and well-being in patients with heart failure:the metoprolol CR/XL randomized intervention trial in congestive heart failure(MERIT-HF)[J].JAMA,2000,283(10):1295-1302.
2Guzzetti S,La Rovere MT,Pinna GD,et al.Different spectral components of 24 h heart rate variability are related to different modes of death in chronic heart failure[J].Eur Heart J,2005,26(4):357-362.
4Swedberg K,Cleland J,Dargie H,et al.Guidelines for the diagnosis and treatment of chronic heart failure;executive summary(update 2005):the task force for the diagnosis and treatment of chronic heart failure of the european society of cardiology[J].Eur Heart J,2005,26(11):1115-1140.
